about
New Perspectives on the Use of Phytochemicals as an Emergent Strategy to Control Bacterial Infections Including BiofilmsCholine Binding Proteins from Streptococcus pneumoniae: A Dual Role as Enzybiotics and Targets for the Design of New AntimicrobialsBiosurfactants Produced by Marine Microorganisms with Therapeutic ApplicationsCan we prevent antimicrobial resistance by using antimicrobials better?Chemical inhibitors of the type three secretion system: disarming bacterial pathogensOrigin and proliferation of multiple-drug resistance in bacterial pathogensDermatophytic defensin with antiinfective potentialDysregulated mitochondrial and chloroplast bioenergetics from a translational medical perspective (Review)A Dormant Microbial Component in the Development of PreeclampsiaA Cationic Amphiphilic Random Copolymer with pH-Responsive Activity against Methicillin-Resistant Staphylococcus aureusCombinations of β-lactam or aminoglycoside antibiotics with plectasin are synergistic against methicillin-sensitive and methicillin-resistant Staphylococcus aureusA model-guided analysis and perspective on the evolution and epidemiology of antibiotic resistance and its futureAntibiotics May Trigger Mitochondrial Dysfunction Inducing Psychiatric DisordersThe slippery difficulty of ever containing drug resistance with current practicesInducing optimal substitution between antibiotics under open access to the resource of antibiotic susceptibility.Structure-activity relationship studies of the tricyclic indoline resistance-modifying agent.New business models for antibiotic innovationCationic methacrylate polymers as topical antimicrobial agents against Staphylococcus aureus nasal colonizationA bacterial toxin inhibits DNA replication elongation through a direct interaction with the β sliding clamp.Safety, tolerability, and efficacy of GSK1322322 in the treatment of acute bacterial skin and skin structure infections.In vitro and in vivo antibacterial activities of cranberry press cake extracts alone or in combination with β-lactams against Staphylococcus aureus.Antibiotic resistance: a primer and call to actionA simple assay to screen antimicrobial compounds potentiating the activity of current antibiotics.Bio-inspired synthesis yields a tricyclic indoline that selectively resensitizes methicillin-resistant Staphylococcus aureus (MRSA) to β-lactam antibioticsSynergistic antimicrobial activity of Camellia sinensis and Juglans regia against multidrug-resistant bacteriaBactericidal monoclonal antibodies specific to the lipopolysaccharide O antigen from multidrug-resistant Escherichia coli clone ST131-O25b:H4 elicit protection in mice.Predicting the in vivo mechanism of action for drug leads using NMR metabolomicsThe Effect of Food and Formulation on the Pharmacokinetics, Safety, and Tolerability of GSK1322322 in Healthy Volunteers.Enhancing the utility of existing antibiotics by targeting bacterial behaviour?Nitric oxide release: part II. Therapeutic applications.Characterization and prediction of the mechanism of action of antibiotics through NMR metabolomics.Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality.Antimicrobial Peptide Novicidin Synergizes with Rifampin, Ceftriaxone, and Ceftazidime against Antibiotic-Resistant Enterobacteriaceae In Vitro.Second Generation Modifiers of Colistin Resistance Show Enhanced Activity and Lower Inherent ToxicityNew Structural Templates for Clinically Validated and Novel Targets in Antimicrobial Drug Research and Development.Polydim-I antimicrobial activity against MDR bacteria and its model membrane interaction.Ultrastructural changes in methicillin-resistant Staphylococcus aureus induced by positively charged silver nanoparticlesAerosolized antimicrobial agents based on degradable dextran nanoparticles loaded with silver carbene complexes.Effect of H2 blockade and food on single-dose pharmacokinetics of GSK1322322, a peptide deformylase inhibitor antibacterial.Targeted Treatment for Bacterial Infections: Prospects for Pathogen-Specific Antibiotics Coupled with Rapid Diagnostics
P2860
Q26741342-854EAD12-7765-416E-97E6-FFEA667180D8Q26744448-4E1CCD5C-8933-45BD-9752-89810926EAE0Q26768448-A07F3849-3FB0-4686-A830-5EC84712ABB0Q26829707-C8013A44-647E-4B3D-8181-7AC5E71DE009Q27013353-B2B0F84C-C8D5-4E41-B322-945008D496E5Q27023284-466B589A-F84A-4DDB-8E4B-7BA988478F31Q27679095-32F3EEF7-DC45-4C25-A824-A5B968F6FBC5Q28066841-D52B39F4-61A0-433D-92AF-3927F6CB26B5Q28069689-C2D5A1E5-4966-45EF-AEB3-AE4BDB5F8C48Q28468450-2E897989-2E3B-4F0C-B39F-D2D49EDBE2B6Q28543476-B480A5A8-83A5-4389-AFDF-FBA75F3DF6D1Q28655580-69882A19-BD30-4A7E-AB46-A6692AF01A46Q28816988-2015B3AF-AED2-4B65-AA9D-2922D66A082AQ30151574-F5117395-5707-4E1B-883D-C350BF2AB7E7Q30489356-B03AC552-8283-462A-A8F4-B59FEAC123B7Q33598767-C8F268DF-0624-4976-8209-C211139CDDF4Q33667548-5348F089-2F85-4608-B5C5-52F51BCF7308Q34033741-DB18E82E-F237-495F-A5B1-F5C01D4655E0Q34385523-EFAEA9FB-850B-498A-8364-7CF0FEFA4FF7Q34596497-FD07E514-DB00-46AF-AC24-385C984A61C0Q34690899-C8238F7D-0B45-4CAF-81FC-210F793CA2A2Q34765528-7427DFB8-BC44-42B7-9CCA-34FE28ABD1B1Q34830742-CBEDD2AF-F26D-4C32-A002-FF7865C0E123Q34982564-9EEE9EA4-CA91-4F36-B9A0-600060607B08Q35568127-4157B7ED-6174-40F7-9DFC-CD7449B8E332Q35607916-AF6FD5D1-2411-4FC5-8442-5266B3DAFE85Q35685462-921AE532-D9DA-4A01-8F7D-C87E90911586Q35742017-A220A88F-36D0-4C52-92E5-0D5ACC9D661CQ35853204-7CE17275-4EBC-43EA-9CEA-17EF111C1702Q35926097-D753E0EF-4D37-4170-BF6E-B3FCE0BB4B90Q36012460-9DAF2157-E399-406A-AD2E-EC10B471A1E3Q36051713-A6DF3EF3-87CF-4718-9DFA-8D0E634EF35FQ36075871-C4BE7CB0-A68F-4781-9BB9-FF9F1876BD97Q36080468-E21E1282-E8AD-426D-80A4-08D4754DC9ABQ36153263-A0755269-77C1-4991-81FD-D3E00D1BFAB6Q36389493-D032154A-C33B-406C-BA37-AB1D2EBEF4B6Q36389808-4495E491-367E-4CFC-AFC1-8390967703CEQ36630649-96F7C4E4-8A18-41D7-BD07-EC8B0068CD47Q37026678-BE4B8A98-3887-46CE-B3F6-6F2FBAF1DA8EQ37087480-608FA7A2-AC8A-4F30-BEF2-D4C96AC8753C
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Novel classes of antibiotics or more of the same?
@ast
Novel classes of antibiotics or more of the same?
@en
Novel classes of antibiotics or more of the same?
@nl
type
label
Novel classes of antibiotics or more of the same?
@ast
Novel classes of antibiotics or more of the same?
@en
Novel classes of antibiotics or more of the same?
@nl
prefLabel
Novel classes of antibiotics or more of the same?
@ast
Novel classes of antibiotics or more of the same?
@en
Novel classes of antibiotics or more of the same?
@nl
P2093
P2860
P1476
Novel classes of antibiotics or more of the same?
@en
P2093
Anthony R M Coates
Gerry Halls
P2860
P304
P356
10.1111/J.1476-5381.2011.01250.X
P407
P577
2011-05-01T00:00:00Z